Vitamin D3 (Cholecalciferol)Third Party Manufacturing in India

Vitamin D3 (Cholecalciferol) works by regulating calcium and phosphorus homeostasis, which is fundamental for maintaining healthy bones and teeth.

After being absorbed or synthesized in the skin, it undergoes two hydroxylations—first in the liver to calcifediol, and then in the kidneys to its active form, calcitriol. Calcitriol binds to the Vitamin D receptor (VDR) in the intestines and bones. This interaction helps the body significantly increase the intestinal absorption of dietary calcium and phosphorus, and promotes proper bone mineralization and remodeling.

Unlike plant-derived Vitamin D2, Vitamin D3 (Cholecalciferol) more effectively raises and maintains serum Vitamin D levels. It is highly effective and well-tolerated for patients experiencing bone disorders, osteomalacia, and general Vitamin D deficiency.

Therapeutic Uses

Vitamin D3 (Cholecalciferol) is prescribed for the treatment of:

• Osteoporosis and Bone Loss: Promotes calcium absorption to increase bone density and reduce fracture risk in older adults.
• Rickets and Osteomalacia: Cures softening and weakening of bones in children and adults caused by severe vitamin deficiency.
• Vitamin D Deficiency: Rapidly restores adequate serum 25-hydroxyvitamin D levels in patients with limited sun exposure or malabsorption.
• Hypoparathyroidism: Helps manage low blood calcium levels associated with underactive parathyroid glands.

Why Manufacturers Choose Vitamin D3 (Cholecalciferol)

With rising global awareness of Vitamin D deficiency, Cholecalciferol has become a staple in prophylactic and therapeutic nutrition. Its versatility allows it to be formulated into a wide array of formats, from highly concentrated softgel capsules (e.g., 60,000 IU) to pediatric drops and chewable tablets.

This makes Vitamin D3 (Cholecalciferol) one of the most sought-after molecules for third party manufacturing in India, with consistent demand from PCD franchise operators across orthopedic, pediatric, and general medicine segments, as well as export-oriented companies.